Latest Head and neck cancer Stories
Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/
LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Oral Cancer Detection Test For Primary Care Physicians GARDEN CITY, N.Y., June 25, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium
Inovio Responds to False and Misleading Speculation Regarding Immunotherapy Study BLUE BELL, Pa., June 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Inovio Targets Most Rapidly Increasing Cancer in Men BLUE BELL, Pa., June 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
NEWPORT BEACH, Calif., June 9, 2014 /PRNewswire-USNewswire/ -- Mark Karan, former lead guitarist for the post Grateful Dead band, The Other Ones, and Joe Pulitano, drummer for the Grateful Dead
LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells -- often by blowing them apart -- without harming surrounding normal organs.
There are currently 148 known strains of the human papillomavirus, and a new study led by NYU Langone Medical Center reveals that 69 percent of otherwise healthy US adults are infected with one or more strains.
CALGARY, May 20, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
- Emitting flashes of light; glittering.